B Brooks Laboratories Limited: management transactions · India · SEBI (PIT + SAST) SEBI:brooks-laboratories-limited IN IN · SEBI (PIT + SAST)
Browse the full management transaction log of Brooks Laboratories Limited, a publicly traded company based in India. Shares are listed on IN IN, under the oversight of SEBI (PIT + SAST). The latest transaction was reported on 15 November 2024 (Sale). Among the most active insiders: Atul Ranchal. Every trade is openly available.
Last declaration on 15 November 2024
Declarations 9 total
Executives ● Sale0 SEBI
€738,794 480,000 shares @ €1.5392
Equity Shares
SEBI:b36574d4c4d7ce272d452e8f8839134dc3030e22 · 14 Nov 2024
Executives ● Sale0 SEBI
€177,625 115,404 shares @ €1.5392
Equity Shares
SEBI:e76705333bf284441bb26a9cc6c403115da84e98 · 14 Nov 2024
Executives ● Sale0 SEBI
€603,558 395,011 shares @ €1.528
Equity Shares
SEBI:7361016fe5153b3980a39a384e44e370e48d1db1 · 14 Nov 2024
Executives ● Sale0 SEBI
€307,831 200,000 shares @ €1.5392
Equity Shares
SEBI:53b334759ed97bf9ead26638a2a4792ae24a354e · 14 Nov 2024
Executives ● Purchase0 SEBI
€38,856 46,868 shares @ €0.829
Equity Shares
SEBI:8b5318a655b1c2b0f319b3d7924cd4ab71b0ce99 · 30 Aug 2023
Ideal exit: 26 May 2024 (T+270) Executives ● Purchase0 SEBI
€3,895 4,698 shares @ €0.829
Equity Shares
SEBI:0f436face1cd7f05bd28d65e079a23741aaca1d7 · 30 Aug 2023
Ideal exit: 26 May 2024 (T+270) Executives ● Purchase0 SEBI
€75,404 90,952 shares @ €0.829
Equity Shares
SEBI:5baaae745d15b852f68e398dd8b57396bd6be4fd · 30 Aug 2023
Ideal exit: 26 May 2024 (T+270) Executives ● Purchase0 SEBI
€58,838 70,970 shares @ €0.829
Equity Shares
SEBI:38dcf33c2b778f74898baa76c403eb7acc0195a9 · 30 Aug 2023
Ideal exit: 26 May 2024 (T+270) Executives ● Purchase0 SEBI
€58,838 70,970 shares @ €0.829
Equity Shares
SEBI:ff516be05cf79472e3120f38edd95ff7ba6411c7 · 30 Aug 2023
Ideal exit: 26 May 2024 (T+270)